A detailed history of Larson Financial Group LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Larson Financial Group LLC holds 18 shares of RPRX stock, worth $452. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 2 800.0%
Holding current value
$452
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$25.63 - $29.27 $410 - $468
16 Added 800.0%
18 $0
Q4 2023

Feb 01, 2024

BUY
$26.21 - $29.22 $52 - $58
2 New
2 $0
Q4 2020

Jan 14, 2021

SELL
$36.12 - $50.05 $7,946 - $11,011
-220 Closed
0 $0
Q3 2020

Oct 08, 2020

BUY
$38.56 - $48.36 $8,483 - $10,639
220 New
220 $9,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.